Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
10 Information Technology Stocks Whale Activity In Today's Session
Peeling Back The Layers: Exploring Gilead Sciences Through Analyst Insights
Gilead Sciences Analyst Ratings
Wells Fargo's 'Core' Stocks: GOOGL, HD, KO, and More
Wells Fargo's 'Value Equity' Stocks: VZ, AZO, KR, and More
Salesforce Rises as Baird Makes It Top Large-cap Software Pick
Oracle Vs. Salesforce: Cloud Wars Heat Up, Stocks Take Off
U.S. Tweaks 2025 Medicare Price Negotiation Process
Decoding Salesforce's Options Activity: What's the Big Picture?
Allegion Analyst Ratings
10 Information Technology Stocks With Whale Alerts In Today's Session
Salesforce's GenAI Platform AgentForce 'On Par' With Microsoft: Analyst
Salesforce Shares Are Trading Higher After Northland Capital Markets Upgraded the Stock From Market Perform to Outperform and Raised Its Price Target From $270 to $400.
Dr. Reddy's Signs Voluntary Licensing Agreement With Gilead Sciences To Manufacture And Commercialise Lenacapavir In India And Other Countries
Competitor Analysis: Evaluating Salesforce And Competitors In Software Industry
This Salesforce Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Bristol-Myers Tops Growth Chart Among S&P 500 Healthcare Stocks in Q3
SPDR MarketAxess Investment Grade 400 Corporate Bond ETF Declares Monthly Distribution of $0.3784
Gilead Signs Deals With Six Drugmakers for Generic Lenacapavir